Edap Tms SA
NASDAQ:EDAP

Watchlist Manager
Edap Tms SA Logo
Edap Tms SA
NASDAQ:EDAP
Watchlist
Price: 2.47 USD -0.8% Market Closed
Market Cap: 91.6m USD
Have any thoughts about
Edap Tms SA?
Write Note

Edap Tms SA
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Edap Tms SA
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Edap Tms SA
NASDAQ:EDAP
Revenue
€60.4m
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
10%
Biomerieux SA
PAR:BIM
Revenue
€3.8B
CAGR 3-Years
6%
CAGR 5-Years
9%
CAGR 10-Years
9%
Carmat SA
PAR:ALCAR
Revenue
€5.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biosynex SA
PAR:ALBIO
Revenue
€104m
CAGR 3-Years
-32%
CAGR 5-Years
26%
CAGR 10-Years
45%
Visiomed Group SA
PAR:ALVMG
Revenue
€13.7m
CAGR 3-Years
-10%
CAGR 5-Years
9%
CAGR 10-Years
2%
Amplitude Surgical SA
PAR:AMPLI
Revenue
€106m
CAGR 3-Years
9%
CAGR 5-Years
1%
CAGR 10-Years
N/A
No Stocks Found

Edap Tms SA
Revenue Breakdown

Breakdown by Geography
Edap Tms SA

Not Available

Breakdown by Segments
Edap Tms SA

Total Revenue: 60.4m EUR
100%
Product: 60.4m EUR
100%

Edap Tms SA
Glance View

Market Cap
91.2m USD
Industry
Health Care

EDAP TMS SA is a holding company, which through its subsidiary engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. The company is headquartered in Vaulx-En-Velin, Auvergne-Rhone-Alpes and currently employs 227 full-time employees. The firm operates worldwide via an extensive network of corporate offices, subsidiaries and distribution partners. The firm invests in Research & Development, partnering with INSERM French public laboratory and international medical research institutions. Company's activity is organized in two divisions: HIFU and UDS (including lithotripsy activities). The firm is developing HIFU technology (High Intensity Focused Ultrasound) in non-invasive treatment of prostate conditions with its range of Robotic HIFU devices, Ablatherm Fusion and Focal One. The firm is also developing ESWL (Extracorporeal ShockWave Lithotripsy) and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications.

EDAP Intrinsic Value
7.06 USD
Undervaluation 65%
Intrinsic Value
Price

See Also

What is Edap Tms SA's Revenue?
Revenue
60.4m EUR

Based on the financial report for Dec 31, 2023, Edap Tms SA's Revenue amounts to 60.4m EUR.

What is Edap Tms SA's Revenue growth rate?
Revenue CAGR 10Y
10%

Over the last year, the Revenue growth was 10%. The average annual Revenue growth rates for Edap Tms SA have been 13% over the past three years , 9% over the past five years , and 10% over the past ten years .

Back to Top